Diagnostic Imaging

Diagnostic Imaging

Global Diagnostic Imaging Market to Reach US$41.0 Billion by 2030

The global market for Diagnostic Imaging estimated at US$29.0 Billion in the year 2023, is expected to reach US$41.0 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. X-ray Imaging, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$9.4 Billion by the end of the analysis period. Growth in the MRI segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.8 Billion While China is Forecast to Grow at 7.2% CAGR

The Diagnostic Imaging market in the U.S. is estimated at US$8.8 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Diagnostic Imaging Market - Key Trends & Drivers Summarized

Diagnostic imaging is a critical tool in modern medicine, enabling the visualization of the internal structures of the body non-invasively to diagnose, monitor, and treat medical conditions effectively. This field includes a variety of techniques such as X-ray radiography, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and nuclear medicine including positron emission tomography (PET) and single-photon emission computed tomography (SPECT). Each of these modalities serves distinct purposes and is chosen based on the specific medical conditions and the part of the body being examined. For instance, X-rays are often used for viewing bones and detecting fractures, while soft tissues are better visualized by MRI. Ultrasound is frequently used in obstetrics and cardiology to examine the fetus during pregnancy and assess cardiac functions. Nuclear medicine provides functional information about a person’s body, detecting molecular activity and can pinpoint disease in its earliest stages before they are apparent with other imaging tests.

Technological advancements have vastly improved the capabilities of diagnostic imaging. Innovations such as digital imaging and 3D reconstruction have enhanced image quality and reduced exposure to radiation. The integration of artificial intelligence (AI) with imaging technologies is transforming the field, enabling faster and more accurate analyses of images. AI algorithms help in detecting patterns that may be missed by the human eye, assisting radiologists in diagnosing diseases such as cancer more effectively. Furthermore, the development of portable imaging devices has expanded the reach of diagnostic services, allowing for point-of-care services that are particularly valuable in emergency settings and in rural or under-resourced areas. This accessibility improvement is vital for timely diagnosis and treatment, significantly impacting patient outcomes. Additionally, advances in hybrid imaging techniques, such as PET/CT and PET/MRI, allow for simultaneous imaging of anatomical and biochemical functions, providing a more comprehensive assessment and aiding in precise disease localization and management.

The growth in the diagnostic imaging market is driven by several factors, including the aging global population, the rising prevalence of chronic diseases, technological advancements in imaging modalities, and increasing healthcare expenditure. As the population ages, there is a higher incidence of conditions such as cardiovascular diseases, cancers, and neurological disorders, all of which require diagnostic imaging for effective management. Chronic diseases are also becoming more common across all age groups, necessitating frequent monitoring and evaluation, which supports the demand for imaging services. Technological advancements not only enhance the quality and efficiency of diagnostic imaging but also expand its applications, leading to broader clinical adoption. Additionally, healthcare systems worldwide are focusing more on preventive care and early diagnosis, which further drives the demand for advanced imaging solutions. The increasing investment in healthcare infrastructure, especially in emerging economies, and the growing acceptance of hybrid and advanced imaging modalities contribute to the robust growth of this market. Thus, diagnostic imaging continues to be an indispensable part of modern medical practice, with ongoing innovations ensuring its expanding role in healthcare delivery.

Select Competitors (Total 66 Featured) -

• Barco NV
• Agfa-Gevaert NV
• Analogic Corporation
• Brainlab AG
• Adelaide Health Care
• Bracco Diagnostics, Inc.
• Accuray, Inc.
• Bracco SpA
• Biodex Medical Systems, Inc.
• Brain Scientific Inc.
• Alliance Medical Limited
• Asahi Roentgen Ind. Co., Ltd.
• A. Menarini Asia-Pacific Holdings Pte., Ltd.
• Beijing Wandong Medical Technology Co., Ltd.
• Bonraybio Company Limited

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.